Applying Trauma-Informed Care and Harm Reduction Principles to Optimize HIV/HCV Care for PEH

Target Audience

The educational design of this activity addresses the needs of primary care, infectious disease, public health, and preventative medicine physicians, physician assistants, nurse practitioners, registered nurses, pharmacists, and social workers involved in the treatment of patients with HIV and hepatitis C virus (HCV), specifically those experiencing homelessness.

Program Overview

People experiencing homelessness (PEH) are significantly affected by HIV, HCV, and substance use disorders (SUDs). It is critical that clinicians understand not only how to link these patients to care and utilize community organization, but to have a foundational knowledge of treatment principles that should guide clinician-patient interactions. In this 1-hour webinar, Dr. Stacey Trooskin and licensed clinical social worker, Juliana Wallace, discuss the basics of language around discussing health care for PEH and the principles of trauma-informed care and harm reduction. The training will also highlight examples of, and implementation strategies for, these founding principles for health care for PEH.

Educational Objectives

After completing this activity, the participant should be better able to:

• Identify strategies to optimize outreach for HIV and HCV testing and linkage to care for PEH
• Identify key principles of harm reduction and trauma-informed care to optimize HIV and HCV care among PEH
• Identify community-based opportunities and logistics for colocation of HIV and HCV healthcare services with SUD and housing programs

Agenda

• 12:00 PM  Welcome & Introduction
• 12:05 PM  Epidemiology of HIV and HCV among PEH
• 12:15 PM  Appropriate language to discuss healthcare for PEH
• 12:25 PM  What is trauma-informed care?
• 12:40 PM  Exploring harm-reduction practices
• 12:50 PM  Question & Answer Session

Physician Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and Integritas Communications.  Global is accredited by the ACCME to provide continuing medical education for physicians.

Physician Credit Designation

Global designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education

Global is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.

This educational activity for 1.0 contact hour is provided by Global. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

Pharmacist Accreditation Statement

Global is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.

Credit Designation

Global designates this continuing education activity for 1.0 contact hour (0.10 CEUs) of the Accreditation Council for Pharmacy Education. (Universal Activity Number - 0530-9999-22-099-L02-P)

This is a knowledge-based activity.

National Association of Social Workers

This program is approved by the National Association of Social Workers (Approval #886551415-4067) for 1.0 continuing education contact hour.

Global Contact Information

For information about the accreditation of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com.

Instructions to Receive Credit

In order to receive credit for this activity, the participant must attend the live webinar, and complete the posttest and program evaluation. Pharmacist learners must check CPE monitor within 30 days for their credit.

Fee Information & Refund/Cancellation Policy

There is no fee for this educational activity.

Disclosures of Conflicts of Interest

Global adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Global are required to disclose all financial relationships with any ineligible company within the past 24 months to Global.  All financial relationships reported are identified as relevant and mitigated by Global in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Global to assure objectivity and that the activity is free of commercial bias. 

All relevant financial relationships have been mitigated.

The faculty have the following relevant financial relationships with ineligible companies:

Stacey B. Trooskin, MD, PhD, MPH: Consulting Fees: Theratechnologies Inc.; Contracted Research: Gilead Sciences, Inc.

Juliana Wallace, LCSW, CADS III: Nothing to disclose

The following planners and managers have no relevant financial relationships with ineligible companies:

Rhys Williams, MSN, FNP-C, RN, Lindsay Borvansky, Andrea Funk, Liddy Knight, Ashley Cann, Lauren Sinclair, Chad Gurdgiel, LSW, Gena Dolson, MS, Elizabeth Manheim, PhD, Jim Kappler, PhD

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the US Food and Drug Administration. Global and Integritas Communications do not recommend the use of any agent outside of the labeled indications. 

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

We would like to thank HealthHIV and HealthHCV for their contributions and support.

This activity is jointly provided by Global Education Group and Integritas Communications.

This activity is supported by independent educational grants from AbbVie Inc., Gilead Sciences, Inc., and ViiV Healthcare. ViiV Healthcare was not involved in the development of content or selection of faculty for this educational activity.